Ilya Kirgner

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern

Inbal Farkash, Tali Feferman, Noy Cohen Saban et al. · Cell Reports · 2021 · 67 citations · Full text

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine

H Maayan, Ilya Kirgner, Odit Gutwein et al. · Journal of Thrombosis and Haemostasis · 2021 · 47 citations · Full text

Vaccination, Thrombosis, Bnt162b2 Vaccine +9

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

David J. Kuter, Waleed Ghanima, Nichola Cooper et al. · Blood · 2025 · 27 citations · Full text